{"organizations": [], "uuid": "3dffb32c28d87df50fb9505fbd21659cad7390c5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180413.html", "section_title": "Archive News &amp; Video for Friday, 13 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/idUSL8N1RQ18M", "country": "US", "domain_rank": 408, "title": "BRIEF-WSE Admits To Trade Shares Of OncoArendi Therapeutics", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.022, "site_type": "news", "published": "2018-04-13T16:26:00.000+03:00", "replies_count": 0, "uuid": "3dffb32c28d87df50fb9505fbd21659cad7390c5"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/idUSL8N1RQ18M", "ord_in_thread": 0, "title": "BRIEF-WSE Admits To Trade Shares Of OncoArendi Therapeutics", "locations": [], "entities": {"persons": [], "locations": [{"name": "warsaw", "sentiment": "none"}, {"name": "wa", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 13 (Reuters) - ONCOARENDI THERAPEUTICS SA ( IPO-ORT.WA )\n* ON THURSDAY WARSAW STOCK EXCHANGE (WSE) ADMITTED THE COMPANYâ€™S SERIES A, B, C, D AND F SHARES TO TRADE AS OF APRIL 12\n* IT HAS ALSO ADMITTED TO TRADE 2.0 MLN OF RIGHTS TO SERIES F SHARES AS OF APRIL 12\n* EARLIER IN MARCH, ONCOARENDI THERAPEUTICS SET THE MAXIMUM ISSUE PRICE IN THE IPO AT 33 ZLOTY PER SHARE\nSource text: [ bit.ly/2GU5Gde ]\nFurther company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://bit.ly/2GU5Gde", "https://www.youtube.com/user/ReutersVideo", "https://twitter.com/reuters", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-13T16:26:00.000+03:00", "crawled": "2018-04-14T13:42:14.106+03:00", "highlightTitle": ""}